drugset / Trial / NCT07639931

Key Diagnostic & Therapeutic Technologies for Severe Acute High Altitude Disease (SAHAD): Integration and Application

NCT07639931

Not yet recruiting 3035 enrolled Tibet Autonomous Region People's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to establish a key technical system for the diagnosis and treatment of severe acute mountain sickness based on real-world clinical data in Xizang, develop standardized diagnosis and treatment protocols and an intelligent early warning model, validate its efficacy through multicenter studies, and innovate diagnostic and therapeutic technologies. It will achieve early identification, precise diagnosis, standardized treatment, and intelligent warning of severe acute mountain sickness, comprehensively improving its prevention, control and treatment success rate.

Timeline

Start
2026-07-01
Primary completion
2028-12-20
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 20 ppm Inhaled
Subject Nitric Oxide Other / unclassified 40 ppm Inhaled